Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5h credit for physicians, pharmacists, and nurses.
New Insulin Options For Patients With T1D
1) Welcome to a tweetorial on new insulin options for treating T1D! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! I...
Hypertension Management in Aortic Dissection
1) Welcome to a tweetorial on #hypertension management in #AorticDissection! Accredited for 0.50 CE/CME credits by @academiccme: physicians, nurses,...
Using New-Generation K+ Binders to Treat Acute Hyperkalemia
2) . . . Supported by educational grant funding from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. Follow this thread for credit. And here is a...
The Primary Care Management of Diabetic Kidney Disease (DKD) Covering Management of Hyperglycaemia in DKD, Delaying the Progression of DKD and Changing Renal Guidelines.
Remember: protect your kidneys, save your heart! Expert author @drkevinfernando. #MedTwitter #cardiotwitter #Nephpearls @goKDIGO...
Initiating New Anti-thrombotic Therapy into the Treatment Regimen of a Patient with PAD
2) Accredited for 0.5 credits by @academiccme: physicians, nurses, pharmacists! Expert faculty @dlbhattmd. Supported by Abbott, AstraZeneca, Bayer,...
De-escalation of P2Y12 Inhibitor Monotherapy PCI
1) Welcome to a tweetorial on de-escalation of P2Y12 inhibitor monotherapy after #PCI! Accredited for 0.50 credits by @academiccme: physicians,...
The Effects of Dapagliflozin on Worsening Heart Failure
Earn 0.5 CE/CME credits: physicians, nurses, pharmacists! Expert faculty @mkosiborodmd #medtwitter @academiccme #cardiotwitter— cardio-met...
Management of a Challenging IWSTEMI
2) . . . Supported by Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. Follow this thread for credit. And here is a case . . .— cardio-met...
GLP-1 RA Therapy for T2D with CVD
This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter...
New-Generation Potassium Binders to Facilitate Guidelines-Based RAASi Therapy
This activity is supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. In case you missed the tweetorial on Twitter...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.
Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.
"Estimating the lifetime risk of MI, stroke or CV death, using the LIFEtime-perspective model for individualizing CVD prevention strategies in apparently healthy people, yielded similar results in moderate and high CV risk classes." This is the rationale for identifying . . .
Join us tomorrow for the launch of a new accredited tweetorial – a case-based program on evidence-based management of #PAD. Free CE/CME for physicians, nurses, pharmacists! Expert author @JoshuaBeckmanMD. FOLLOW US and tell your colleagues to do the same! #MedTwitter #cardio